Cargando…
Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management
BACKGROUND & AIMS: Immune checkpoint inhibitors (ICIs) improve the survival of patients with advanced tumors. However, immune-related adverse events limit the use of ICIs. Although liver toxicity has been concerned gradually, little is known about bile duct injury associated with ICIs. Hence, th...
Autores principales: | Pi, Borui, Wang, Jin, Tong, Yifan, Yang, Qiao, Lv, Fangfang, Yu, Yunsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734631/ https://www.ncbi.nlm.nih.gov/pubmed/34482313 http://dx.doi.org/10.1097/MEG.0000000000002280 |
Ejemplares similares
-
Influence of Metabolic Risk Factors on the Risk of Bacterial Infections in Hepatitis B-Related Cirrhosis: A 10-Year Cohort Study
por: Yang, Qiao, et al.
Publicado: (2022) -
Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients
por: Imoto, Koji, et al.
Publicado: (2019) -
Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung Cancer
por: Tan, Peixin, et al.
Publicado: (2023) -
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
por: Yamada, Kentaro, et al.
Publicado: (2021) -
Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management
por: Coukos, Alexander, et al.
Publicado: (2023)